Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InMode ( (INMD) ) has issued an announcement.
On February 2, 2026, InMode issued a statement responding to market speculation surrounding a publicly announced non-binding proposal from Steel Partners Holdings L.P. to acquire 51% of the company’s outstanding shares and other related rumors. The company confirmed that it is evaluating potential strategic alternatives and has established a committee of independent directors, supported by external legal and financial advisers, to oversee this review in line with their fiduciary duties and the interests of all shareholders. InMode cautioned that there is no assurance the ongoing strategic review will lead to any transaction or other outcome, and indicated it does not plan to provide further updates on the process unless required under applicable law or regulation.
The most recent analyst rating on (INMD) stock is a Buy with a $17.50 price target. To see the full list of analyst forecasts on InMode stock, see the INMD Stock Forecast page.
Spark’s Take on INMD Stock
According to Spark, TipRanks’ AI Analyst, INMD is a Outperform.
The score is driven primarily by strong financial performance (high profitability, very strong balance sheet, and solid cash generation) and a supportive low P/E valuation. Offsetting these strengths are a weaker technical trend (trading below key moving averages) and an earnings-call backdrop showing significant year-over-year declines in revenue and margins despite reiterated guidance and encouraging consumables/international growth.
To see Spark’s full report on INMD stock, click here.
More about InMode
InMode Ltd., based in Yokneam, Israel, is a leading global provider of innovative medical technologies that develops, manufactures, and markets devices using proprietary radio-frequency (RF) technology. Its minimally invasive RF platforms support a broad range of procedures and treatments in plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology, targeting physicians and clinics seeking advanced aesthetic and surgical solutions.
Average Trading Volume: 721,901
Technical Sentiment Signal: Hold
Current Market Cap: $993M
See more data about INMD stock on TipRanks’ Stock Analysis page.